OneMedForum SF 2012 is around the corner and we are gearing up to present some of the most promising companies and technologies, as well as innovative approaches to funding the growth economy. In this issue:
Mark Tauscher, CEO of PLC Medical Systems [PLCSF.OB] says the company is developing an automated device that measures urine output and replenishes the same amount of fluid intravenously before, during and after catheterization and radiological interventions in patients with CIN.
Hepregen, a presenting company at OneMedForum SF 2012, is focused on improving and commercializing its microliver platform, HepatoPac, into the drug-development pipeline of pharmaceutical and biotechnology companies.
Panels and Special Sessions present significant opportunities at OneMedForum San Francisco 2012.
Del Mar Pharmaceuticals plans clinical trials for GBM treatment.
Peter Winter, consultant to the biotechnology industry, brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.